Synonyms: ER-306323 | ER306323 | Orserdu® | RAD-1901 | RAD1901
elacestrant is an approved drug (FDA & EMA (2023))
Compound class:
Synthetic organic
Comment: Elacestrant is an orally bioactive, selective, non-steroidal dual estrogen receptor degrader (SERD)/selective estrogen receptor modulator (SERM; with antagonist action) [6]. It was developed primarily for antineoplastic potential (via its SERD action at high concentrations) [3]. It has also demonstrated potential to treat the vasomotor symptoms of the menopause with estrogen-like effects detected at low concentrations (SERM activity), but the pharmacology in this setting is very complex [4]. Elacestrant crosses the blood-brain barrier, so is predicted to provide efficacy against breast cancer metastases in the brain.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes. EMA (2023) | FDA (2023) |
IUPAC Name ![]() |
(6R)-6-[2-[ethyl-[[4-[2-(ethylamino)ethyl]phenyl]methyl]amino]-4-methoxyphenyl]-5,6,7,8-tetrahydronaphthalen-2-ol |
International Nonproprietary Names ![]() |
|
INN number | INN |
10247 | elacestrant |
Synonyms ![]() |
ER-306323 | ER306323 | Orserdu® | RAD-1901 | RAD1901 |
Database Links ![]() |
|
BindingDB Ligand | 349630 |
CAS Registry No. | 722533-56-4 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL4297509 |
DrugBank Ligand | DB06374 |
GtoPdb PubChem SID | 479821130 |
PubChem CID | 23642301 |
RCSB PDB Ligand | I0V |
Search Google for chemical match using the InChIKey | SIFNOOUKXBRGGB-AREMUKBSSA-N |
Search Google for chemicals with the same backbone | SIFNOOUKXBRGGB |
Search PubMed clinical trials | elacestrant |
Search PubMed titles | elacestrant |
Search PubMed titles/abstracts | elacestrant |
UniChem Compound Search for chemical match using the InChIKey | SIFNOOUKXBRGGB-AREMUKBSSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | SIFNOOUKXBRGGB-AREMUKBSSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Elacestrant (links to external site)
Cat. No. HY-19822 |